Cargando…
Prophylactic use of levosimendan in preoperative setting for surgical repair of congenital heart disease in children
INTRODUCTION: Low cardiac output syndrome (LCOS) is a significant cause of morbidity and the leading cause of mortality after pediatric cardiac surgery. Levosimendan has been shown safe and effective in pediatrics to treat LCOS. We aimed to review our local strategy with preoperative prophylactic Le...
Autores principales: | Wannaz, L., Boillat, L., Perez, M. H., Di Bernardo, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394616/ https://www.ncbi.nlm.nih.gov/pubmed/37539009 http://dx.doi.org/10.3389/fped.2023.1205971 |
Ejemplares similares
-
Effect of Prophylactic Levosimendan on All-Cause Mortality in Pediatric Patients Undergoing Cardiac Surgery—An Updated Systematic Review and Meta-Analysis
por: Wang, Hongbai, et al.
Publicado: (2020) -
Levosimendan for Pediatric Anomalous Left Coronary Artery From the Pulmonary Artery Undergoing Repair: A Single-Center Experience
por: Wang, Chunrong, et al.
Publicado: (2018) -
Preoperative Hemoglobin Level, Oxygen Saturation and Postoperative Outcomes in Children With Cyanotic Congenital Heart Disease: A Propensity-Score Matching Analysis
por: Zhou, Dan, et al.
Publicado: (2022) -
Necessity of Prophylactic Extrapleural Chest Tube During Primary Surgical Repair of Esophageal Atresia: A Systematic Review and Meta-Analysis
por: Ladefoged, Martin Riis, et al.
Publicado: (2022) -
Microcirculatory Differences in Children With Congenital Heart Disease According to Cyanosis and Age
por: González, Rafael, et al.
Publicado: (2019)